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Haemophilus influenzae type b is a common cause of invasive bacterial disease, especially among children in
underdeveloped countries. The type b polysaccharide capsule is a polymer of ribose and ribitol-5-phosphate
and is a critical determinant of virulence. Expression of the type b capsule is dependent upon the cap b locus,
which consists of three functionally distinct regions, designated regions 1 to 3. Region 3 contains the hcsA and
hcsB genes, which share significant homology with genes that have been implicated in encapsulation in other
pathogenic bacteria but have unclear functions. In this study, we inactivated hcsA alone, hcsB alone, and both
hcsA and hcsB together and examined the effects of these mutations on polysaccharide transport and bacterial
virulence properties. Inactivation of hcsA alone resulted in accumulation of polysaccharide in the periplasm
and a partial decrease in surface-associated polysaccharide, whereas inactivation of hcsB alone or of both hcsA
and hcsB together resulted in accumulation of polysaccharide in the periplasm and complete loss of surfaceassociated polysaccharide. All mutations eliminated serum resistance and abrogated bacteremia and mortality
in neonatal rats. These results indicate that the hcsA and hcsB gene products have complementary functions
involved in the transport of polysaccharide across the outer membrane and are essential for virulence.
Encapsulated strains of H. influenzae are an important cause
of sepsis, meningitis, epiglottitis, and septic arthritis in young
children, especially in underdeveloped countries where vaccination rates are low (26). These strains are characterized by
the presence of one of six structurally and serologically distinct
polysaccharide capsules, referred to as serotypes a through f
(28). Type b isolates are most common and express a capsule
that is a polymer of ribose and ribitol-5-phosphate (polyribosylribitolphosphate [PRP]) (9). The genes responsible for the
biosynthesis and surface expression of the type b capsule are
located in the cap b locus, which contains three functionally
distinct regions (19), similar to capsulation loci in other bacteria. Most isolates contain a partial tandem duplication of the
cap b locus, with the two copies separated by a 1.2-kb bridge
segment and flanked by IS1016 elements.
The three functionally distinct regions in the cap b locus are
referred to as regions 1 to 3. Region 1 contains genes designated bexA, bexB, bexC, and bexD and encodes an ABC transporter system involved in the export of capsular polysaccharide
to the bacterial surface (18). Region 2 contains genes currently
designated orf1 to orf4 and encodes enzymes involved in biosynthesis of ribose-ribitol-5-phosphate disaccharide subunits
(41). Region 3 contains genes referred to as hcsA and hcsB,
which share significant homology with genes in a number of
other encapsulated pathogens, including Neisseria meningitidis
(lipA and lipB), Escherichia coli K1 and E. coli K5 (kpsC and
kpsS), Mannheimia (Pasteurella) haemolytica (wbrA and wbrB),
P. multocida A:1 (phyA and phyB), P. multocida B:2 (wcbA and
wcbO), Burkholderia mallei, and Burkholderia pseudomallei (4,
7, 10, 13, 22, 29, 32, 34). Overall, the hcsA and lipA gene
products are 60.4% identical, and the hcsB and lipB gene
products are 55.1% identical. Based on analysis of mutations in

Polysaccharide capsules are common cell surface components in bacterial pathogens that cause systemic disease. Based
on in vitro studies, it is known that polysaccharide capsules
mediate resistance to important host defense mechanisms, including phagocytosis and complement-mediated killing. In addition, capsules may prevent desiccation in the environment,
potentially facilitating transmission between hosts. Consistent
with these observations, genetically defined nonencapsulated
mutants of Streptococcus spp., Actinobacillus pleuropneumoniae, Klebsiella pneumoniae, Staphylococcus aureus, Pasteurella
multocida, and Haemophilus influenzae have reduced virulence
in animal models (3, 11, 20, 24, 36, 39, 44, 45).
Bacterial capsules are long polysaccharide chains consisting
of smaller repeating units. The composition of these repeating
units varies among bacterial species and is usually distinct
among different serotypes of the same species. Capsular polysaccharide biosynthesis occurs in the cytoplasm, and the resulting polysaccharide is then transported across the cytoplasmic
membrane into the periplasm and then across the outer membrane to the bacterial surface. Typically, capsules are substituted with phospholipids at the reducing end of the polysaccharide chains (14, 21, 30, 33). According to the prevailing
model, lipidation of capsular polysaccharide is required for
transport across the inner membrane and possibly for anchoring to the outer membrane (30).
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MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. H. influenzae strain Eagan
is a type b clinical isolate that was originally isolated from a child with meningitis
and has a partial duplication of the cap b locus, like most type b isolates (35). H.
influenzae strain Rd is a longtime laboratory strain and is a spontaneous capsuledeficient mutant of a type d isolate, containing an IS1016 element but no cap
gene (12). H. influenzae strain RM135 is a transformant of strain Rd that harbors
a single copy of the cap b locus and expresses the type b capsule (47). E. coli
DH5␣ has been previously described (15).
The plasmid pUC18K carries a kanamycin resistance cassette from Enterococcus faecalis and was a generous gift from Philippe Sansonetti (Pasteur Institute,
Paris, France) (23). The plasmid pUC4K carries the kanamycin resistance cassette from Tn903 and was obtained from Pharmacia (43). The plasmids pUC19
and pACYC184 were obtained from New England Biolabs and have been described previously (6, 46).
H. influenzae strains were grown in brain heart infusion (BHI) broth supplemented with hemin and NAD, on BHI agar supplemented with NAD and hemin
(BHI-DB agar), or on chocolate agar, as described previously (2, 37). E. coli
strains were grown on Luria-Bertani (LB) agar or in LB broth. Antibiotic concentrations were as follows: for H. influenzae, kanamycin at 55 g/ml and chloramphenicol at 2 g/ml, and for E. coli, kanamycin at 50 g/ml and ampicillin at
100 g/ml.
General molecular techniques. DNA ligations, restriction endonuclease digestions, gel electrophoresis, and PCR were performed according to standard techniques (31). Plasmids were introduced into E. coli by chemical transformation
(31). Linearized DNA was introduced into H. influenzae made competent using
the M-IV method of transformation (16).
Construction of hcsA and hcsB mutants. To create an hcsA null mutant without
affecting the hcsB gene downstream, we generated an in-frame deletion in hcsA,
leaving the remainder of region 3 intact. To prepare this construct, we cloned the
hcsA and hcsB genes and flanking sequence into pUC19, ligating three separate
PCR-amplified fragments. The PCR primers were designed to create BamHI sites
on both sides of hcsA, making it possible to excise hcsA and preserve the correct
reading frame for hcsB. To allow selection of transformants carrying this construct, the kanamycin cassette from pUC4K was introduced into a unique SalI
site in the IS1016 element downstream of the hcsB gene. As a control, an
analogous construct containing wild-type region 3 and a kanamycin cassette in
the IS1016 element was generated.
To create an hcsB null mutant, we generated PCR fragments corresponding to
the 5⬘ and 3⬘ ends of hcsB and cloned these fragments into pUC19. The PCR
primers were designed to create a BamHI site at the point of fusion of the 5⬘ and
3⬘ fragments, making it possible to insert the kanamycin cassette from pUC4K
and interrupt the hcsB gene.
To create an hcsA hcsB double mutant, we began by generating two separate
plasmids. As a first step, we cloned a 6.2-kb fragment containing hcsA and
flanking sequence into pUC19 and then inserted the kanamycin cassette from
pUC18K into the Eco47III site in the hcsA gene. As a second step, we exploited
the plasmid harboring hcsB with a unique internal BamHI site and inserted the
chloramphenicol cassette from pACYC184 into this BamHI site.
Constructs were linearized and then transformed into strain RM135 made
competent using the M-IV method of Herriott et al. (16). Transformants were
selected by plating on BHI-DB agar containing kanamycin or kanamycin plus
chloramphenicol, as appropriate.

Detection and quantitation of type b polysaccharide. The presence of the type
b polysaccharide capsule on the bacterial surface was detected semiquantitatively
using a Wellcogen H. influenzae b kit (Alexon-Trend, Inc., Minnesota), which
contains latex particles coated with antibody against PRP. Levels of agglutination
were graded as nonexistent (⫺), weak (⫹), moderate (⫹⫹), and strong (⫹⫹⫹).
Bacterial cellular fractions were prepared as described previously (20). In brief,
bacterial cultures were incubated to exponential phase and were pelleted by
centrifugation at 12,000 ⫻ g at 4°C for 15 min. Culture supernatant was saved as
a source of extracellular released polysaccharide. To recover periplasm-associated polysaccharide, the bacterial pellet was resuspended in 0.03 M Tris (pH 7.4)
containing 3 mM EDTA and 25% (wt/vol) sucrose, incubated for 10 min at 25°C,
and pelleted by centrifugation. The pellet was rapidly resuspended in ice-cold
distilled water and incubated for 10 min at 4°C and then centrifuged at 12,000 ⫻
g at 4°C for 15 min. Supernatant, containing periplasmic polysaccharide, was
saved (41). Control assays measuring glucose-6-phosphate dehydrogenase as a
cytoplasmic marker and alkaline phosphatase as a periplasmic marker confirmed
that the periplasmic fraction was free of cytoplasmic contents.
Polysaccharide content in samples was measured by enzyme-linked immunosorbent assay (ELISA) as described previously (27). The capture antibody
used for coating ELISA plates was burro anti-PRP (a generous gift from John
Robbins and Rachel Schneerson, Bureau of Biologics), and bound antigen was
detected with a mouse monoclonal anti-PRP antibody (a gift from Bruce Green,
Wyeth) and horseradish peroxidase-conjugated anti-mouse secondary antibody. The
peroxidase substrate used for supernatant and periplasm-associated polysaccharide
samples was SureBlue TMB microwell peroxidase substrate (Kirkegaard & Perry,
Gaithersburg, Maryland).
Immunoelectron microscopy. To prepare bacteria for analysis by electron
microscopy, organisms initially were fixed in 4% paraformaldehyde-0.1% glutaraldehyde (Polysciences Inc., Warrington, PA) in 100 mM piperazine-N,N⬘-bis(2ethanesulfonic acid) (PIPES) phosphate buffer, pH 7.2, for 1 h at 4°C. Subsequently, samples were rinsed extensively in deionized water to remove phosphate
ions and were then stained en bloc with aqueous 2% uranyl acetate for 1 h at 4°C.
Samples were then dehydrated and infiltrated with LR Gold resin (Ted Pella,
Inc., Redding, CA) under the following conditions: 50% ethanol for 30 min at
4°C, 70% ethanol for 30 min at ⫺20°C, 90% ethanol for 30 min at ⫺20°C, 1:1 LR
Gold:ethanol for 60 min at ⫺20°C, 3:1 LR Gold:ethanol for 60 min at ⫺20°C,
two changes of 100% LR Gold (60 min and overnight) at ⫺20°C, and two
changes of 100% LR Gold with 0.1% initiator (benzoin methyl ether) (4 h and
overnight) at ⫺20°C. Samples were then embedded in fresh LR Gold resin with
initiator and polymerized at ⫺20°C under UV light for 48 h.
Samples were sectioned with a Leica Ultracut UCT ultramicrotome (Leica
Microsystems Inc., Bannockburn, IL). Seventy- to 80-nm sections were immunolabeled with mouse monoclonal anti-PRP antibody and subsequently with
18-nm-diameter colloidal gold-conjugated goat anti-mouse immunoglobulin G.
Sections were stained with uranyl acetate and lead citrate and viewed on a JEOL
1200EX transmission electron microscope (JEOL USA Inc., Peabody, MA). All
labeling experiments were processed in parallel with controls in which the primary antibody was omitted. Controls were consistently negative at the concentration of gold-conjugated secondary antibodies used in these studies.
Purification of H. influenzae capsular polysaccharide. To purify capsular polysaccharide, periplasm-associated polysaccharide was recovered as described
above (41), and then absolute ethanol was added to achieve a final concentration
of 25% (vol/vol). After incubation for 2 h, bacterial debris was removed by
centrifugation at 25,000 ⫻ g for 20 min. Polysaccharide was then precipitated by
adding absolute ethanol to a final concentration to 80% (vol/vol) and was collected by centrifugation at 2,000 ⫻ g for 10 min. The precipitated polysaccharide
was resuspended in distilled water, and Cetavlon (hexadecyltrimethyl ammonium
bromide) was added to the suspension to achieve a final concentration of 0.5%.
After 1 h of mixing, the polysaccharide-Cetavlon complex was collected by
centrifugation at 10,000 ⫻ g for 20 min. The polysaccharide-Cetavlon complex
was resuspended in 0.3 M NaCl, and polysaccharide was recovered by centrifugation at 10,000 ⫻ g for 20 min. The relative quantity of polysaccharide in each
sample was determined by adding orcinol to samples and measuring the A665,
using serial dilutions of ribose as a standard.
Thin-layer chromatography. Capsular polysaccharide preparations from 1.5
liters of late-exponential-phase cultures were chromatographed on silica gelcoated aluminum plates (Whatman) with butanol-methanol-water (5:3:2) (42).
The dried plates were stained with orcinol-ferric chloride (Bial’s reagent)
(Sigma, St. Louis, MO).
Serum resistance assay. Serum from healthy adult donors was collected,
pooled, and stored at ⫺80°C as 100-l aliquots. Bactericidal assays were performed for 30 min at 37°C using 20% serum. Percent survival was determined as
the ratio of viable counts after incubation in active serum to viable counts after
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the N. meningitidis lipA and lipB genes, it appears that lipA and
lipB play a role in surface localization and possibly lipidation of
capsular polysaccharide, although published reports are conflicting (13, 40). Whether hcsA and hcsB have functions like
those of lipA and lipB remains unclear.
In this study, we inactivated the H. influenzae type b hcsA
and hcsB genes and examined the resulting mutants for polysaccharide transport, polysaccharide lipidation, and virulence
properties. Our results established that hcsA and hcsB have
complementary functions involved in the transport of the serotype b polysaccharide across the outer membrane and are
essential for in vitro serum resistance and for virulence in
neonatal rats. We found no evidence that hcsA and hcsB play
a role in polysaccharide lipidation.
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FIG. 1. Diagram of region 3 of the H. influenzae type b cap b locus,
showing the locations of hcsA and hcsB relative to region 2 and the
flanking IS1016 element.

RESULTS
Inactivation of H. influenzae serotype b hcsA and hcsB genes.
The genetic organization of region 3 in the H. influenzae cap b
locus is shown in Fig. 1. This region contains the hcsA and hcsB
genes, which are both transcribed away from region 2 and are
separated from each other by 259 nucleotides of noncoding
DNA. The IS1016 element that flanks the cap b locus begins 79
nucleotides downstream of the hcsB stop codon.
To define the functions of the hcsA and hcsB gene products,
we constructed three mutants of H. influenzae strain RM135,
including an hcsA null mutant with an in-frame deletion in
hcsA (RM135hcsA), an hcsB mutant with a kanamycin cassette
inserted into hcsB (RM135hcsB), and an hcsA hcsB double
mutant with a kanamycin cassette inserted into hcsA and a
chloramphenicol cassette inserted into hcsB (RM135hcsAhcsB). To facilitate recovery of the hcsA in-frame deletion
mutant, we introduced a kanamycin cassette into the IS1016
element downstream of the hcs region, allowing selection for
transformants on the basis of kanamycin resistance. As a control, we generated a strain with wild-type hcsA and hcsB genes
and a kanamycin cassette in the flanking IS1016 element
(RM135-IS). All mutants were confirmed to have the appropriate deletion or insertion using PCR and Southern analysis
(data not shown).
Localization of capsular polysaccharide in the hcsA, hcsB,
and hcsA hcsB mutants. To assess the effects of inactivation of
hcsA, of hcsB, and of both hcsA and hcsB on surface-associated
polysaccharide capsule, we examined the abilities of the parent
and mutant strains to agglutinate latex particles coated with
antibody against the H. influenzae type b capsule in semiquantitative assays. As shown in Table 1, wild-type RM135 and
RM135-IS agglutinated latex particles strongly. In contrast,
RM135hcsA displayed very weak agglutination, and RM135hcsB
and RM135hcsA-hcsB displayed no agglutination, results comparable to observations with nonencapsulated strain Rd. These
results indicate that mutations in hcsA, in hcsB, and in both
hcsA and hcsB result in diminution of surface-associated polysaccharide capsule.
To address whether the decrease in surface-associated polysaccharide capsule in the RM135hcsA, RM135hcsB, and

RM135RM135hcsA-hcsB mutants was a consequence of a
block in translocation across the outer membrane or a defect in
anchoring to the bacterial surface, we used a sandwich ELISA
to quantify polysaccharide in periplasm fractions and in culture
supernatants. In performing these assays, we used wild-type
RM135 and RM135-IS as positive controls and nonencapsulated strain Rd as a negative control. As shown in Fig. 2,
examination of periplasmic fractions revealed similar quantities of polysaccharide in wild-type RM135 and RM135-IS and
in all three mutant strains. In contrast, examination of culture
supernatants revealed abundant polysaccharide in wild-type
RM135 and RM135-IS, a ⬃60% decrease in released polysaccharide in RM135hcsA, and no detectable released polysaccharide in RM135hcsB and RM135hcsA-hcsB.
To extend these results, we used a murine monoclonal antibody against PRP and performed immunoelectron microscopy on thin sections from wild-type RM135, RM135hcsA,
RM135hcsB, and Rd. As shown in Fig. 3A, wild-type strain
RM135 had immunoreactive polysaccharide in the cytoplasm,
in the periplasm, and on the bacterial surface (Fig. 3A), and
strain Rd had no appreciable immunolabeling of any compartment (Fig. 3B), as expected. Consistent with our latex
agglutination and ELISA results, RM135hcsA had wild-type
levels of labeling in the cytoplasm and periplasm and a
significant decrease in labeling on the bacterial surface (Fig.
3C), and RM135hcsB had appreciable labeling in the cytoplasm and periplasm but no clear labeling on the bacterial
surface (Fig. 3D).
Phospholipid modification of capsular polysaccharide in the
hcsA, hcsB, and hcsA hcsB mutants. Previous work has suggested that N. meningitidis homologs of hcsA and hcsB may
play a role in substitution of a 1,2-diacylglycerol lipid moiety at
the reducing end of the N. meningitidis serogroup B capsule
polymer (13). To assess whether the hcsA and hcsB gene products affect lipidation of the type b polysaccharide, we purified
periplasmic polysaccharide from wild-type RM135, RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB and then compared these
polysaccharide samples by thin-layer chromatography (lipidated and nonlipidated polysaccharides migrate differently on
thin-layer chromatography plates). As shown in Fig. 4, all polysaccharide samples migrated in identical fashion, arguing
against any defect in lipid modification of polysaccharide from
the mutant strains. To confirm this result, we separated samples by using a Tris-borate-buffered polyacrylamide gel electrophoresis system and again observed no difference in migration (data not shown).

TABLE 1. Latex agglutination of wild-type RM135, RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB with latex particles
coated with antibody against PRPa
Strain

Latex agglutinationb

RM135 ......................................................................................⫹⫹⫹
RM135hcsA..............................................................................⫹
RM135hcsB ..............................................................................⫺
RM135hcsA-hcsB.....................................................................⫺
Rd..............................................................................................⫺
a

PRP is the H. influenzae type b polysaccharide.
Levels of agglutination were graded as nonexistent (⫺), weak (⫹), moderate
(⫹⫹), and strong (⫹⫹⫹).
b
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incubation in heat-inactivated serum (56°C for 30 min to inactivate complement
function).
Virulence studies. Virulence studies using the infant rat model were performed essentially as described previously (35). Sprague-Dawley albino rats used
for these experiments were purchased from Taconic Farms (Germantown, New
York). Infant rats that were 5 or 6 days old were randomized among litters.
Intraperitoneal inoculations were carried out with 100 l of bacterial suspension
adjusted to a density of ⬃103 CFU/ml. To evaluate the development of systemic
infection, a blood sample of 10 l was obtained from a dorsal foot vein, serially
diluted in phosphate-buffered saline, and spread on chocolate agar plates to
determine the number of viable bacteria in blood. Blood samples were obtained
24 h, 48 h, and 96 h after inoculation.
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Sensitivity to serum complement of the hcsA, hcsB, and hcsA
hcsB mutants. Previous studies have demonstrated the importance of surface-associated capsule in H. influenzae resistance
to complement-mediated killing (17, 25, 38). With this information in mind, we compared wild-type RM135, RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB in 30-minute serum resistance assays, using RM135-IS and Rd as controls. Using the
ratio of viable counts in 20% normal human serum to viable
counts in 20% heat-inactivated human serum as a measure of
serum resistance, wild-type RM135 and RM135-IS were ⬃80%
to 100% resistant (Fig. 5). In contrast, the RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB mutants were completely
susceptible to complement-mediated killing, analogously to
strain Rd (Fig. 5). These observations are consistent with our
quantitative latex agglutination and ELISA results and suggest
that a certain threshold level of surface-associated capsule is
required for serum resistance.
Virulence in the infant rat bacteremia model by the hcsA,
hcsB, and hcsA hcsB mutants. To investigate the role of hcsA
and hcsB in virulence, we compared wild-type RM135,
RM135hcsA, RM135hcsB, and RM135hcsA-hcsB in the infant
rat bacteremia model in two independent experiments using an
intraperitoneal route of infection. In experiment 1, among rats
infected with wild-type strain RM135, 50% were dead after
72 h and 70% were dead after 96 h (Fig. 6A). All rats infected
with either RM135hcsA or RM135hcsB survived, indicating
that inactivation of either hcsA or hcsB attenuates virulence.
One pup infected with RM135hcsA-hcsB died, but this pup was
much smaller than its littermates, raising the possibility that
factors other than infection contributed to death. In experiment 2, results were similar, although mortality among rats
infected with wild-type RM135 was generally higher (Fig. 6B).
In this experiment, infection with wild-type RM135 resulted in
death for 70% of rats after 48 h and 100% of rats after 72 h. All
rats infected with RM135hcsA, RM135hcsB, or RM135hcsAhcsB survived during this experiment.
To complement our assessment of mortality, we collected
blood samples at 24, 48, and 96 h after inoculation and determined the magnitude of bacteremia in surviving animals. As

shown in Table 2, animals infected with wild-type RM135 had
high numbers of CFU per ml of blood at all time points during
both experiments. In contrast, none of the animals infected
with RM135hcsA, RM135hcsB, or RM135hcsA-hcsB had bacterial counts higher than the limit of detection (100 CFU per
ml of blood) in either experiment.
These observations are consistent with our quantitative latex
agglutination and ELISA results and our serum resistance assays and suggest that a certain threshold level of surface-associated capsule is required for virulence in animals.
DISCUSSION
The H. influenzae type b cap b locus contains three functional regions, designated region 1, region 2, and region 3 (19).
Recent work has established that region 3 contains genes,
called hcsA and hcsB, with homology to genes in a number of
other encapsulated bacteria (32). In this study, we examined
the function of hcsA and hcsB. Based on analysis of hcsA, hcsB,
and hcsA hcsB mutants, we found that both the hcsA and the
hcsB gene products are required for efficient transport of capsular polysaccharide across the outer membrane. Consistent
with the decrease in surface-associated polysaccharide in these
mutants, we observed abrogation of serum resistance and elimination of virulence in experimental rats.
The hcsA and hcsB gene products share homology with gene
products in other pathogenic bacteria that express group II
capsules, including N. meningitidis, E. coli K1, E. coli K5, M.
haemolytica, P. multocida A:1, P. multocida B:2, B. mallei, and
B. pseudomallei (4, 7, 10, 13, 22, 29, 34). In some cases, the
hcsA and hcsB homologs are present as an independent unit in
a distinct region of the capsule gene complex, which is analogous to the arrangement in H. influenzae (for example, lipA and
lipB in region B in N. meningitidis). In other cases the hcsA and
hcsB homologs are interspersed among other capsule-related
genes, as illustrated by the kpsS and kpsC genes at the end of
the kpsFEDUCS gene cluster in region 1 in E. coli K1 and E.
coli K5.
In initial studies of the N. meningitidis lipA and lipB genes,
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FIG. 2. Quantity of PRP (the H. influenzae type b polysaccharide capsule) in the periplasms and culture supernatants of wild-type RM135,
RM135hcsA, and RM135hcsB and of RM135hcsA-hcsB, RM135-IS, and Rd. PRP content was measured by ELISA, and values were compared to
values for wild-type RM135, which were set at 100%. RM135-IS is a control strain that contains intact hcsA and hcsB genes and harbors a
kanamycin cassette in the IS1016 element downstream of hcsB (analogous to the kanamycin cassette in the IS1016 element in strain RM135hcsA).
Rd is a control strain that lacks capsule genes.
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the cloned meningococcal capsule gene complex (cps) was
examined in E. coli K-12 (13). In this heterologous background, deletion of the lipA and lipB genes resulted in intracellular accumulation of capsule polymers lacking a phospholipid substitution, leading to the proposal that the lipA and lipB
gene products mediate polysaccharide lipidation prior to transport of capsule polymers to the bacterial surface (13). However, more recently, Tzeng et al. generated lipA and lipB
mutations in N. meningitidis strain NMB and observed intracellular accumulation of capsule polymers that were clearly
lipidated (40). Interestingly, studies of E. coli kpsS and kpsC
have also yielded mixed results. In particular, in E. coli K-12
carrying the complete K5 capsule gene cluster on a plasmid, a

kpsS insertion mutation and a kpsC deletion mutation resulted
in cytoplasmic accumulation of capsule polysaccharide lacking
the phosphatidic-3-deoxy-manno-2-octulosonic acid substitution (5). In contrast, Cieslewicz and Vimr found that Tn10
insertion mutations in either kpsC or kpsS in the chromosome
in an E. coli K-12-K1 hybrid strain were associated with intracellular accumulation of capsule polymers with wild-type lipidation (8). Together, these observations raise the possibility
that the function of the lipA and lipB and the kpsC or kpsS
genes may be altered in the K-12 genetic background. In the
present study, we generated mutations in hcsA and hcsB in H.
influenzae directly and observed accumulation of polysaccharide in the periplasm, suggesting a block in transport across the
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FIG. 3. Immunoelectron micrographs of wild-type RM135, Rd, RM135hcsA, and RM135hcsB. PRP was immunolabeled with mouse monoclonal anti-PRP antibody followed by 18-nm colloidal gold-conjugated goat anti-mouse immunoglobulin G. (A) Wild-type RM135. (B) Rd.
(C) RM135hcsA. (D) RM135hcsB. Bars, 0.2 m.
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outer membrane. Based on thin-layer chromatography and
electrophoretic mobility of polysaccharide purified from the
periplasm, the hcsA and hcsB mutations had no effect on lipidation.

FIG. 6. Virulence of wild-type RM135, RM135hcsA, RM135hcsB,
and RM135hcsA-hcsB in infant rats after intraperitoneal inoculation.
Survival was measured at 24, 48, 72, and 96 h after inoculation.
(A) Plot of the results of experiment 1. (B) Plot of the results of
experiment 2.

Fractionation of polysaccharide in the hcsA, hcsB, and hcsA
hcsB mutants revealed reduced quantities of surface-localized
polysaccharide with inactivation of hcsA and a complete absence of surface-localized polysaccharide with inactivation of
either hcsB alone or hcsA and hcsB together. These results
suggest that the HcsA and HcsB proteins have distinct functions involved in transport of polysaccharide from the

TABLE 2. Bacteremia in infant rats after intraperitoneal
inoculation with wild-type RM135, RM135hcsA,
RM135hcsB, or RM135hcsA-hcsB
Expt
no.

FIG. 5. Serum resistance of wild-type RM135, RM135hcsA, and
RM135hcsB and of RM135hcsA-hcsB, RM135-IS, and Rd. Samples
were incubated in 20% human serum for 30 min at 37°C. Percent
survival was determined as the ratio of viable counts after incubation
in active serum to viable counts after incubation in heat-inactivated
serum. RM135-IS is a control strain that contains intact hcsA and hcsB
genes and harbors a kanamycin cassette in the IS1016 element downstream of hcsB (analogous to the kanamycin cassette in the IS1016
element in strain RM135hcsA). Rd is a control strain that lacks capsule
genes.

1

2

Bacteremia ata:
Strain
24 h

RM135
RM135hcsA
RM135hcsB
RM135hcsA-hcsB
RM135
RM135hcsA
RM135hcsB
RM135hcsA-hcsB

48 h

1.5 ⫻ 10
⬍100
⬍100
⬍100
8.0 ⫻ 107
⬍100
⬍100
⬍100
7

96 h

3.6 ⫻ 10
⬍100
⬍100
⬍100
9.0 ⫻ 108
⬍100
⬍100
⬍100
8

7.0 ⫻ 104
⬍100
⬍100
⬍100
ND
⬍100
⬍100
⬍100

a
Numbers represent geometric means of the numbers of CFU/ml of blood.
Limit of detection was 100 CFU/ml. ND, not done.
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FIG. 4. Thin-layer chromatography of polysaccharide samples
purified from the periplasms of wild-type RM135, RM135hcsA,
RM135hcsB, and RM135hcsA-hcsB. For each sample, similar quantities of polysaccharide were spotted onto a gel-coated aluminum plate,
and chromatography was performed with butanol-methanol-water (5:
3:2). Polysaccharide was visualized by staining with orcinol-ferric chloride. The arrow indicates the polysaccharide.
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